Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Tempus AI, Inc. (TEM : NSDQ)
 
 • Company Description   
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Number of Employees: 2,400

 
 • Price / Volume Information   
Yesterday's Closing Price: $59.05 Daily Weekly Monthly
20 Day Moving Average: 3,291,074 shares
Shares Outstanding: 177.91 (millions)
Market Capitalization: $10,505.42 (millions)
Beta: 5.22
52 Week High: $104.32
52 Week Low: $31.36
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -22.64% -22.51%
12 Week -40.52% -41.48%
Year To Date 0.00% 0.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
600 WEST CHICAGO AVENUE SUITE 510
-
CHICAGO,IL 60654
USA		 ph: 800-976-5448
fax: -		 investorrelations@tempus.com http://www.tempus.com
 
 • General Corporate Information   
Officers
Eric Lefkofsky - Chief Executive Officer; Founder and Chairman
James Rogers - Chief Financial Officer
Ryan Bartolucci - Chief Accounting Officer
Peter J. Barris - Director
Eric D. Belcher - Director

Peer Information
Tempus AI, Inc. (HLIS)
Tempus AI, Inc. (AZTA)
Tempus AI, Inc. (APYI)
Tempus AI, Inc. (RNVA)
Tempus AI, Inc. (HMSY)
Tempus AI, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 88023B103
SIC: 7370
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/23/26
Share - Related Items
Shares Outstanding: 177.91
Most Recent Split Date: (:1)
Beta: 5.22
Market Capitalization: $10,505.42 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.33 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.02 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 30.56% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/23/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 20.69
Price/Cash Flow: -
Price / Sales: 9.50
EPS Growth
vs. Year Ago Period: 18.42%
vs. Previous Quarter: 13.89%
Sales Growth
vs. Year Ago Period: 84.72%
vs. Previous Quarter: 6.22%
ROE
12/31/25 - -
09/30/25 - -73.21
06/30/25 - -122.86
ROA
12/31/25 - -
09/30/25 - -13.78
06/30/25 - -18.09
Current Ratio
12/31/25 - -
09/30/25 - 3.28
06/30/25 - 1.54
Quick Ratio
12/31/25 - -
09/30/25 - 3.12
06/30/25 - 1.43
Operating Margin
12/31/25 - -
09/30/25 - -19.87
06/30/25 - -24.06
Net Margin
12/31/25 - -
09/30/25 - -18.45
06/30/25 - -20.98
Pre-Tax Margin
12/31/25 - -
09/30/25 - -22.12
06/30/25 - -24.93
Book Value
12/31/25 - -
09/30/25 - 2.85
06/30/25 - 1.78
Inventory Turnover
12/31/25 - -
09/30/25 - 8.84
06/30/25 - 8.66
Debt-to-Equity
12/31/25 - -
09/30/25 - 2.45
06/30/25 - 2.58
Debt-to-Capital
12/31/25 - -
09/30/25 - 71.04
06/30/25 - 72.05
 

Powered by Zacks Investment Research ©